EMJ GOLD - European Medical Journal

Continue

Pharma News, Views & Analysis

Filter Advertise With Us
Researchers

UK government unveils £400m plan to boost life science sector

The UK Government has launched a £400m public-private investment initiative, aiming to advance the pharmaceutical and life sciences sectors.
The word spotlight on a blue background

Spotlight: August 2024

Catch up on the top pharma news stories from August in our monthly round-up. From the latest on the spread of mpox to new treatment approvals, there’s plenty to discover.

Spoonful of Technology: July-August 2024

We look at the latest examples of how pharma and its partners are working together to develop technology to solve key healthcare challenges.

European Commission gives green light to Roche’s PNH treatment

Roche has secured European Commission approval for its drug crovalimab, marking a significant advancement in the treatment of PNH.

Bavarian Nordic to manufacture 440,000 doses of mpox vaccine

Bavarian Nordic has entered into a significant agreement to manufacture 440,000 additional doses of its vaccine in response to the escalating mpox outbreak.

NHS must adapt for next wave of advanced therapies, warns ABPI

The NHS has made commendable progress in introducing advanced therapies, but it must accelerate preparations for the next wave.
Orange lungs on yellow background

J&J wins FDA approval for chemo-free treatment for lung cancer

The FDA has approved Johnson & Johnson’s new chemotherapy-free combination treatment for patients with non-small cell lung cancer.
Vaccines on blue background

WHO makes urgent call to companies developing mpox vaccines

The World Health Organization has made an urgent call to pharmaceutical companies producing mpox vaccines to submit a Expressions of Interest for Emergency Use Listing (EUL).